Abigail Brooks is an assistant editor for HCPLive. She joined MJH Life Sciences in August 2023 shortly after graduating from Monmouth University where she earned her BA in Communication with a concentration in Public Relations/Journalism and later an MA in Interactive Digital Media. She enjoys traveling, running, and reading books. She can be reached at abrooks@mjhlifesciences.com.
Patients With Vitiligo, End-Stage Renal Disease Face Greater Risk of Infection
January 30th 2024Vitiligo was significantly associated with an increased risk of bacteremia, cellulitis, and herpes zoster and was more common among those with female sex, Black compared to White race, Hispanic ethnicity, hepatitis C infection, and tobacco use.
Read More
Women With Alcohol-Related Liver Disease Face Greater Risk of Mortality Than Men
January 30th 2024Although there was a greater prevalence of ALD and MetALD among male study participants, females had a greater risk of mortality from both SLD phenotypes, highlighting a potentially greater impact of alcohol consumption on women with liver disease than men.
Read More
SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes
January 29th 2024Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.
Read More
Automated AKI Alert Prompts Change of Care, Shows No Impact on Patient Outcomes
January 26th 2024Use of the electronic AKI alert system led to slight improvements in intervention rates and AKI diagnosis, although kidney function and patient-centered outcomes did not differ from patients receiving usual care.
Read More
Pregnant Women in Rural Regions Face Greater HCV, Preterm Birth Burden
January 26th 2024Results showed a 12% incidence of HCV in pregnancy with a preterm birth rate nearly double the national average, although no statistically significant difference in preterm birth rates was observed between HCV-positive and HCV-negative patients.
Read More
Dupilumab's Role in Managing Pediatric EoE, with Evan Dellon, MD, MPH
January 25th 2024We sat down with Evan Dellon, MD, MPH, to discuss the use of dupilumab in pediatric EoE patients, with the agent gaining FDA approval as the first and only indication for this patient population on January 25, 2024.
Read More
Patients with IgA Nephropathy May Not Be Receiving Optimal Supportive Care
January 24th 2024Results called attention to suboptimal blood pressure and proteinuria control as well as a lack of maximal RAASI dosing in a cohort of adult patients with IgAN from the Cure Glomerulonephropathy Network study.
Read More
Achieving SVR Reduces Risk of Cardiovascular Events in Patients with HCV
January 23rd 2024Results highlight the benefit of achieving sustained virological response with DAAs for decreasing patients’ risk of carotid atherosclerosis and peripheral artery disease, especially among those with severe fibrosis.
Read More
Artificial Intelligence Model Predicts HCV Patients At Risk of Treatment Failure
January 19th 2024The XGBoost machine learning model outperformed other AI and logistic regression models for predicting DAA failure, with an AUROC of 1.000 in the training dataset and 0.803 in the validation dataset.
Read More
Corticosteroids Induce Remission in Patients With IgA Nephropathy, Moderate Proteinuria
January 19th 2024Patients with IgAN and urine protein levels of 0.75–3.5 g/d treated with corticosteroids exhibited significantly greater overall and complete remission rates compared to those who received supportive care.
Read More
Renal Failure Risk Group Classification Predicts Kidney Dysfunction in IgAN
January 18th 2024Renal failure risk group classification based on pathological findings from patients’ kidney biopsy, eGFR, and proteinuria was significantly associated with a composite 50% increase in serum creatinine.
Read More
Safety, Efficacy of Tacrolimus for Ulcerative Colitis Not Impacted by Age
January 16th 2024Patients ≥ 65 years of age experienced similar rates of remission and adverse events compared to their younger counterparts, with no significant difference in change in renal function observed between the 2 groups.
Read More
Clinical, Prognostic Factors Affecting Concurrent IgAN and Membranous Nephropathy Outcomes
January 15th 2024Results of the retrospective study suggested blood pressure, serum IgA, potassium, and segmental glomerulosclerosis may be predictive of the rapid progression of renal endpoints in patients with concurrent IgAN and membranous nephropathy.
Read More
Prolonged Perfusion Preserves Donor Livers, Allows Flexible Transplantation Timeline
January 12th 2024Liver transplantation after prolonged preservation with dual hypothermic oxygenated machine perfusion yielded similar outcomes to standard perfusion, showing no compromised donor liver quality and equal safety for recipients.
Read More